Tag: thalidomide

1. Progression-free survival was improved by about 3 months with continuous lenalidomide-dexamethasone compared to standard melphalan-prednisone-thalidomide. 2. Overall survival was also better with continuous lenalidomide-dexamethasone compared to melphalan-prednisone-thalidomide. Evidence Rating Level: 1 (Excellent) Study Rundown: Multiple myeloma (MM) is a disease of plasma cells. Over proliferation of these antibody-producing...
Image: PD In this section, we will highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Exdoxaban versus Warfarin in Patients with Atrial Fibrillation Factor Xa inhibitors have been shown to be noninferior to warfarin for prevention of venous thromboembolism, and dabigatran has been compared for...
Image: CC/Wiki 1. After 8 weeks of treatment, thalidomide demonstrated improved rates of clinical remission as compared to placebo. 2. The mean duration of the remission induced by thalidomide was 181 weeks versus the 6 weeks noted in the placebo group. Evidence Rating Level: 1 (Excellent) Study Rundown: About a quarter of adult...